Skip to content

International Mini-Symposium - Vascular Immunity, Inflammation and Atherosclerosis

International Mini-Symposium - Vascular Immunity, Inflammation and Atherosclerosis

Thursday, January 27, 2022 (1:30 PM - 6:30 PM) (CET)


Atherosclerosis, a chronic inflammatory disease of the arteries, has life-threatening complications, myocardial and cerebral infarcts, two primary causes of death. In pathology, atherosclerosis is characterized by the formation of lipid-laden, fibrous plaques in the intima of the arterial wall, a long-lasting process with years of interplays between lipid deposition, inflammatory infiltration, smooth muscle cell migration and transformation, and fibrotic tissue accumulation. Although the inflammatory property of atherosclerotic plaques was described more than a century ago, a mechanistic understanding of the role of innate and adaptive immunity in atherogenesis has emerged in the last few decades. The current mini-symposium offers an update of the progress in the field of vascular immunity, inflammation and atherosclerosis that has been achieved in recent years. The mini-symposium includes lectures by internationally recognized investigators who will highlight new developments and knowledge in basic, translational and clinical sciences of the mechanisms that promote migration of leukocytes into inflamed tissue, and the consequences of those interactions for the promotion and regression of inflammation. The ultimate goal of this mini-symposium is to elicit critical scientific exchange and collaboration for future research.

Göran K Hansson, Karolinska Institutet, Sweden
Frying fat in the artery wall - Immune inflammation triggered by LDL 

Peter Libby, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA
Immunity and inflammation in atherosclerosis-no longer just a theory

Yong-Jian Geng, University of Texas Health Science Center at Houston, USA
Adaptive immunometabolism in atherosclerosis

Lena Jonasson, Linköping University, Sweden
T cell aging in coronary artery disease

Marc Feldmann, Imperial College London, University of Oxford, UK
Challenges in discovering therapeutic targets

Jan Nilsson, Lund University, Sweden
Active and passive immunization targeting apoB antigens

Daniel Ketelhuth, University of Southern Denmark, Denmark and Karolinska Institutet, Sweden
Targeting immunometabolism in cardiovascular diseases

Esther Lutgens, University of Amsterdam, Netherlands
Agonistic immune checkpoints: target - mechanism – therapy

Giuseppina Caligiuri, University Hospital Xavier Bichat, Paris, France
CD31 as a therapeutic target in atherosclerosis

Norbert Gerdes, University Hospital Düsseldorf, Düsseldorf, Germany
The co-stimulatory axis CD40/CD40L in cellular crosstalk in CVD

Peder S Olofsson, Karolinska Institutet, Sweden
Understanding inflammation requires neuroscience

The mini-symposium will be held entirely on-line via Zoom. Access link will be sent to the registered participants.

January 27, 2022, between 1.00 and 6.30 P.M. (CET).

This is a free event. Participants register by sending their name, and information about their title, affiliation and whether they plan to attend IRL to:

Organizing committee:
Peder S Olofsson, Karolinska Institutet, Sweden
Lena Jonasson, Linköping University, Sweden
Peter Libby, Harvard University Medical School, USA
Yong-Jian Geng, University of Texas Health Science Center at Houston, USA
Anton Gisterå, Karolinska Institutet, Sweden

The Journal of Internal Medicine
International Society of Atherosclerosis
Northern American Vascular Biology Organization

For more information about this event, contact Angela Silveira (

Online via Zoom
Event Contact
Bernadette Englert
Thursday, January 27, 2022 (1:30 PM - 6:30 PM) (CET)
Other Meetings of Interest
Powered By GrowthZone